Latest Breaking News On - Chartered group - Page 10 : comparemela.com

Pepticom s New Spinout Company, PeptiCov, to Focus on COVID-19 JERUSALEM, March 9, 2021 /PRNewswire/ Pepticom, a leader in artificial intelligence peptide drug design and discovery, announced today that it has raised $2.6 million to establish a company to focus on treatments for the SARS-Cov-2 virus, responsible for the COVID-19 outbreak. The company, PeptiCov, will implement Pepticom s AI technology to design, discover and develop novel peptide molecules for effective treatment of the SARS-Cov-2 virus. The funding round was led by the Chartered Group. Unfortunately, COVID-19 and the various viral mutations will likely be with us for a long time and thus effective treatment is key, said Immanuel Lerner, Founder and CEO of Pepticom. PeptiCov is focused on discovering and developing an effective treatment for SARS-Cov-2, which would allow the world to live alongside the virus rather than remain in lockdowns and other drastic measures.

Israel generalPrnewswire pepticomKostenloser wertpapierhandelMaayan eliasEyal agmoniImmanuel lernerGroup technologyShaarei zedek medical center on beyond vaccinesHebrew university of jerusalemCompany contactTel aviv universityGroup logoChartered groupEast asiaHebrew universityShaarei zedek medical center